Literature DB >> 6304193

Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth.

S J Burstin, M W Brandriss, J J Schlesinger.   

Abstract

We studied the effect of antibody on the growth of reovirus, serotypes 1 and 3, in P388D1, a continuous mouse macrophage-like cell line. Enhanced growth of virus was observed when cells were infected in the presence of nonneutralizing monoclonal antibodies or subneutralizing concentrations of either immune ascitic fluids or neutralizing monoclonal antibodies. Both enhancement of viral growth and neutralization were accompanied by an antibody-mediated increase in binding of radiolabeled virus to P388D1 cells. Although neutralization was seen only with monoclonal antibodies directed toward the sigma-1 surface protein of the virus, enhancement was observed with two monoclonal antibodies directed toward other surface proteins. Trypsin treatment of P388D1 cells abrogated enhanced growth of virus mediated by a mouse IgG2a antibody; preincubation with P388D1 with human IgG1 but not IgG2 myeloma proteins also abrogated enhancement by immune ascitic fluid or monoclonal antibody. These observations are compatible with known properties of P388D1 Fc receptors and support the role of the Fc receptor in antibody-mediated infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis.

Authors:  Pranav Danthi; Mark W Hansberger; Jacquelyn A Campbell; J Craig Forrest; Terence S Dermody
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1.

Authors:  H Ochiai; M Kurokawa; K Hayashi; S Niwayama
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  Increase of retroviral infection in vitro by the binding of antiretroviral antibodies.

Authors:  P Legrain; B Goud; G Buttin
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

Review 4.  Interactions of viruses with the immune system.

Authors:  C A Mims
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

5.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Recent developments in immunovirology.

Authors:  R Finberg
Journal:  Surv Immunol Res       Date:  1984

7.  Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.

Authors:  E Rieder; A Berinstein; B Baxt; A Kang; P W Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Neutralizing-enhancing monoclonal antibody recognizes the denatured glycoprotein of viral haemorrhagic septicaemia virus.

Authors:  F Sanz; J M Coll
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.

Authors:  P W Mason; E Rieder; B Baxt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.